期刊文献+

经皮肾镜碎石术在高手术风险病人中的应用探讨 被引量:6

The safety and efficacy of percutaneous nephrolithotomy in high-risk patients
暂未订购
导出
摘要 目的:评价经皮肾镜手术在高危麻醉风险病人中的安全性及有效性。方法:2008年1月至2010年1月回顾性分析178例患者行经皮肾镜手术189次,所有患者的术前情况均使用美国麻醉学学会评分标准进行评分,将患者分为2组,高危险组,评分为Ⅲ或Ⅳ,共39例,低危险组,评分为Ⅰ或Ⅱ,共139例。结果:高危组行经皮肾镜(Percutaneous nephrolithotomy,PCNL)手术42次,低危组共行147次。低危组患者年龄较高危组小(47.6岁与55.2岁)。2组在结石大小及位置上差异无统计学意义。高危组并发疾病平均为2.8种,低危组为0.6种,差异有统计学意义。在术中各种参数的比较中,高危组麻醉时间长于低危组,术中估计出血量差异无统计学意义。2组总的并发症发生率相当。高危组平均术后住院日为7.6 d,低危组为4.8 d,两者差异有统计学意义。高危组结石清除率为83%,低危组结石清除率为94%,两者差异有统计学意义。结论:对于高危的患者来说,PCNL是一种安全有效的治疗方法。 Objective:To discuss the safety and efficacy of percutaneous nephrolithotomy(PCNL) in high-risk patients.Methods: The records of 189 consecutive PCNL procedures performed on 178 patients from January 2008 to January 2010 were retrospective analyzed.The preoperative conditions of the patients were evaluated by American Society of Anesthesiologists(ASA) Scores.The patients were divided into a high-risk group(n=39),which had an ASA score of III or IV,and a low-risk group(n=139) with scores of Ⅰ or Ⅱ.Results:42 procedures were performed in the high-risk group,and 147 procedures in the low-risk group.The low-risk group had a younger age than high-risk group(47.6 vs 55.2 y)(P0.05).There was no difference observed in stone size and location.The mean number of comorbidities in high-risk group was 2.8,and 0.6 in low-risk group;the difference was significant(P0.05).In the comparison of the intraoperative parameters,the general anesthesia time was longer in the high risk group(125.3 vs 102.4 min);no significant difference was observed in the estimated blood loss(128 vs 160 ml)(P0.05).The overall complication rate had no difference between the high-risk(13.2%) and low-risk(10.8%)(P0.05).The mean postoperative hospital stay was 7.6 d in the high-risk group and 4.8 d in the low-risk group respectively;the difference was significant(P0.05).The stone-free rate in the high-risk group was 83%,and 94% in the low-risk group;the difference was significant(P0.05).Conclusion:For the patients with high-risk preoperative conditions,PCNL can be a safe and effective procedure.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2011年第8期999-1001,共3页 Journal of Chongqing Medical University
关键词 经皮肾镜 肾结石 高危患者 percutaneous nephrolithotomy renal stone high-risk patients
  • 相关文献

参考文献13

  • 1Femstrom I, Johansson B.Percutaneous pyelolithotomy:A new extraction technique[J].Scand J Urol Nephrol, 1976,10 (3) : 257-259.
  • 2Preminger G M,Assimos D G,Lingeman J E,et al.AUA guideline on management of staghorn calculi:diagnosis and treatment recommendations[J].J Urol, 2005,173 (6) : 1991-2000.
  • 3Frederic S, Raymond K, Mordechai D, et al.Percutaneous Nephrol- ithotomy for Staghom Caleuli:A Single Center's Experience overl5 Years[J].J Endourol,2009,23(10) : 1669-1673.
  • 4张琦,鲁军,夏术阶,陈辉熔,文伟,邵怡.微创经皮肾镜治疗肾鹿角状结石[J].临床泌尿外科杂志,2006,21(8):630-631. 被引量:22
  • 5Maurice S M,Lutz T,Jens J R.Complications in Percutaneous Nephrolithotomy[J].Euro Urol.2007,51 (4) : 899-890.
  • 6蓝志相,梁建波,王晓平,刘刚,玉海,卢秋维,黄小彬.微创经皮肾镜取石术中高压灌注液对患者的影响[J].中国内镜杂志,2009,15(4):359-361. 被引量:17
  • 7Sutchin R P,George E H,Gyan P.Percutaneous nephrolithotomy can be safely performed in the High-risk Patient[J].Urology, 2010, 75(1) :51-55.
  • 8Matlage B R,Hodges S J,Shah O D,et al.Percutaneous nephrostolithotomy: predictors of length of stay [J].J Urol, 2004, 172 (2) : 1351 - 1354.
  • 9Duvdevani M,Nott L,Ray A A,et al.Percutaneous nephrolithotomy in patients with diabeters mellitus[J].J Endourol, 2009,23 (1):21-26.
  • 10何阳,凡杰,鲁军,夏术阶,唐孝达.微创经皮肾镜治疗2型糖尿病患者上尿路结石[J].中国内镜杂志,2008,14(9):952-954. 被引量:6

二级参考文献31

共引文献47

同被引文献74

  • 1程静林,夏莉,颜莉丽.经皮肾镜碎石取石术的麻醉处理[J].中国实用医刊,2010,37(10):52-53. 被引量:3
  • 2黄健,许可慰,郭正辉,林天歆,谢文练,韩金利,姚友生,黄海.斜卧位微创经皮肾镜取石术55例报告[J].中华泌尿外科杂志,2007,28(1):15-18. 被引量:100
  • 3徐桂彬,李逊,何朝辉,何永忠,雷鸣.微创经皮肾镜取石术出血量影响因素的分析[J].中华泌尿外科杂志,2007,28(7):456-459. 被引量:122
  • 4Tumey BW, Reynard JM, Noble JG, et al. Trends in urological stone disease[J]. BJU Int, 2011, Aug 26. [Epub ahead of print].
  • 5Ozturk E, Yilmazlar T. Factors affecting the mortality risk in elderly patients undergoing surgery [J]. ANZ J Surg, 2007, 77(3): 156-159.
  • 6Cracco CM, Scofone CM, Poggio M, et al. The patient position for PNL: does it matter[J]. Arch hal Urol Androl, 2010, 82(1 ): 30-31.
  • 7Falahatkar S, Allahkhah A, Sohanipour S. Supine percutaneous nephrolithotomy:pro[J]. J Urol, 2011, 8(4): 257-264.
  • 8Xun LI, Zhaohui HE, Kaijun WU, et al. Chinese minimally invasive percutaneous nephrolithotomy:The Guangzhou experience[J]. J Endurol, 2010, 25(9): 1421-1425.
  • 9Patel SR, Leocadio D, Haleblian G, et al. Meta-analysis of complications for percutaneous nephrolithotomy:comparison of techniques [J]. 77th New England AUA Section Meeting, Rio Grande, Pueao Rico, 2008, 25-27.
  • 10DE LA ROSETTE J, ASSIMOS D, DESAI M, et al. The clinical research office of the endourological society percutaneous nephrolithotomy global study: indications, complications, and out- comes in 5803 patients[J]. J Endourol, 2011, 25(1): 11-17.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部